Michael Scolaro

Michael Scolaro

Nov 29, 2017

Group 6 Copy 200
0
References
  • 1. https://www.ncbi.nlm.nih.gov/pubmed/26558876
  • 2. https://www.ncbi.nlm.nih.gov/pubmed/26558876
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Circulating biomarkers of fibrosis in captive gorillas: a pilot study

Heart disease is the leading cause of death for gorillas in captivity. The ultimate goal of this project...

Do dietary supplements extend lifespan and prevent brain disease?

Can a cheap, over the counter pill, prevent the onset of ageing-related diseases and extend lifespan? I...

Affordable 3D-Printed Neural Devices for Spinal Cord Regeneration

Medical treatments for spinal cord injuries are expensive and difficult to test. I want to try to develop...

Backer Badge Funded